News
Organic polymer may lead to better retinal implants
Researchers at the Italian Institute of Technology in Milan are currently working with organic polymer which is a light-sensitive plastic. This new technology may ultimately lead to improved retina...
Resveratrol may prevent leading cause of blindness
An antioxidant found in grapes may hold the key in preventing some of the leading causes of blindness. A recent study conducted by researchers at Washington University School of Medicine in St. Lou...
VEGF Trap-Eye to begin Phase III clinical trials
Currently, patients suffering from myopic macular degeneration due to choroidal neovascularization (CNV) have no well-established treatment options. Bayer HealthCare and Regeneron Pharmaceuticals h...
Intravitreal injections effective for CRVO
Ophthalmologists now have a new treatment at their disposal to effectively treat central retinal vein occlusion (CRVO). Intravitreal triamcinolone injections (a steroid injection) improve or even r...
Aging physicians possible cause for concern
An article in the New York Times explores the problem of aging physicians and the potential problems that can arise. While commercial airl
Bilateral injections just as safe as unilateral
Many patients prefer same-day bilateral anti-VEGF injections over unilateral injections, and a recent study confirms the safety of the bilateral injections.
Down but not out - Macular Degeneration strikes one in sixteen adults age 40 and older
A study which evaluated the incidence of age-related macular degeneration in the United States revealed that it is down to 6.5 percent from the 9.4 percent reported 15 years ago. The details are re...
Modified vitamin A used in new therapy for eye disease
A modified form of vitamin A is hoped to provide a new therapy in the treatment of dry age-related macular degeneration and Stargardt disease. A license agreement between Alkeus Pharmaceuticals and...
FDA approves clinical trial for AMD treatment
The Food and Drug Administration (FDA) has approved a clinial trial which will involve replacing retinal cells with human embryonic stem cell-derived tissues in patients suffering from the dry form...